the volume impacted higher which XXXX, of $XXX relative acquisition as heavily to to of as The well MedTrans, COVID-XX. of was adjusted increase million approximately million, in of revenue related $XXX quarter adjusted the million, segment XXXX Dan. financial was in Thanks, net quarter of and with second Starting recorded revenue diluted million, of consolidated income share. $XX National per million, million compared prior revenue incremental or EBITDA is quarter trip $X.XX $XX second we quarter-over-quarter second attributed to period. to $XXX results, the NEMT of $XX year our our by
of or As discussed was XX% risk from and capitated derived which contracts, are of contracts XX% contracts fee-for-service. our risk, to costs trip from complete last rebate quarter, we revenue. our approximately represented of non-risk, capitated capitated revenue. revenue our where and full have responsibility reconciliation volume Within the primarily of The or is total XX% manage XX% regardless noncapitated
reminder, to received. expense has increase Through COVID, our higher year. with contracts call million that center activity. on contact cap the increase and by third-party costs service related which provisions operational direct Service other NEMT center the based million, The a costs $XXX have volume operations capped. functions and/or all the rebate trip related our revenue compared includes revenue and was higher either prior primarily reconciliation trip to margin As increased driven providers, our been volume the expense to associated and and in transportation $XXX for segment, or profit
benefits to of focus our of reduction automation and and our the specific the on efforts transportation We operating processes. contact continue center modernization cost
which, performing well, previously. negotiated risk are on quarter as increases Utilization again, $XX revenue. contracts XXXX, to and was basis higher $XX But margins customers. We in XX% year-over-year full to our million mentioned Second flat down XXXX. compared NEMT $XX on to the adjusted due our million with impact represent our sequentially our service primarily QX our they expenses million a know in contract, EBITDA of compared
XXXX expect We and steadily anticipate it that increase normalized to throughout early-to-mid XXXX. be by utilization will
ensure size We operational margin our modernized to scale, our major advantage. achieved XX%. and levels adjusted our are We our initiatives EBITDA low-cost believe support will confident of a platform NEMT our and X% competitive modernization these and coupled is expectations business that with platform normalized utilization
XX over for said sales earlier, as platform Dan determinants served other As this with social unique modernized of offerings. million health patients channel
Turning to care our personal segment.
to market. see across We strong personal continue care demand for services our
incentives and expected again, caregiver improve flat in well $XXX XXXX recruitment the concerns half With of million. resulted latter However, later normalize expect government as year, to demand personal EBITDA unemployment growth million into is XXXX, lingering incentives, management. we revenue COVID-XX in in as flat to billable unemployment of this which by the by expense there. because hours, should also Despite care to quarter, in $XX in accelerated effective sequentially adjusted service result X% the driven revenue the increased
ended equivalents and $XX $XXX Moving million to XX, flow second as ModivCare position, with second in the cash of the including our strong operations balance very Cash undrawn XXXX a sheet. $XXX by and provided an million of cash June financial revolver. of was quarter million. quarter
quarter contracts, customer which the increase was XXXX by year-to-date, on in with contracts strong our $XXX associated been of cash and to operations detailed which flow While first ModivCare’s has an payments part year-to-date cash call. reconciliation our million. driven we flow our relate NEMT payable, our earnings from rebate in
repurchased repurchase share to the $XX don’t anticipate year-to-date ModivCare of year. We million the share our of bringing for the shares repurchases any additional During quarter under our million. $XX remainder program, repurchases
we plans to acquisition in ModivCare As the week, of the footprint last expand Care shared Finders personal Care. with Total announced our Northeast care
segment to the our million from of total on net present $XX over which of revenue near expected price of way to generate reach is EBITDA Finders to us trailing transaction synergies. times performance of is $XXX attributes, is to tax personal all-cash Following repurchase annual million, purchase subject Care $XXX in generate million our care and adjustments. $XX our bringing for personal estimated well transaction, goal The approximately billion of the including revenue, annually. the representing million term $X purchase price generating adjusted XX.X of million, in puts transaction $XXX a expected The customer to of EBITDA multiple $XXX value care million,
of operates recovery forward the We are XX% care government anticipated and personal EBITDA the the than on in to our unemployment XX EBITDA line long-term to relative existing in the multiple based following as Finders ModivCare’s with segment. Care between below rates EBITDA personal Finders the reimbursement COVID-XX. state be EBITDA slightly differences growth segment care continue will target forma we higher expect care impact Care at range. pro end XX%, have higher the Finders at margin of our the incentives times which negative in ModivCare’s Including in margin of Care this personal albeit
of immediately anticipate acquisition accretive We in with an and teens XXXX are and excited about the mid-to-high we to accretion earning ModivCare will expectation initial be beyond.
new growth XX% to revenue an cross to Advantage. this mentioned, VRI previously multiple Medicare LTM due mid-teens with in The Dan a is healthcare forward We expectations. another XX% VRI across in the these margins likely top Medicaid of XX% attractive revenue. million, recurring of the similar the the purchase continue believe payer monitoring purchase the announced total companies U.S. all-cash to the is to opportunities years, boasts top-line expected mid-to-high pipeline is remote are As million attractive an represents customary mix, we given over selling highly there strong range. grow from next from the lower market. with in acquisition VRI’s of of will The in XX of driven for price couple by to and Medicaid turns a times while business several VRI’s adjustments, both $XX opportunities is very as $XXX EBITDA Advantage the transaction. focus This EBITDA transactions earlier company be of week. VRI of nearly the million, multiple Medicare from subject terrific one $XX
prior should factored We anticipate cross-selling base third close into the expectations of benefits our case VRI. end the were for quarter. not transactions both to However, these
$XXX of We capacity well have committed full as financing on million as revolver. $XXX our million
is with We place expect range. – to closing EBITDA of ModivCare’s driven the consistent strong This ratio to times in acquisition, currently leverage announced times the the the transactions. September put of pro one to these our expectation time the in in and ModivCare’s mid-three net XXXX. at forma by to closing in be growth Simplura long-term Since debt leverage we net generation. the of financing reduced the prior range into is cash expected acquisition have of Simplura leverage net
ratio remains leverage three target Our times.
So, hold touching down to going Briefly on generation flow strong which be cash investment. pay a XXXX. in debt XX.X% we’ll top-line focused we Matrix’s on in free forward. using Matrix, equity be to continues
offset for Matrix from down XXXX. trials previous of second the rollout of opportunities recorded the quarter was excited XXXX. quarter the quarters testing. solution of million, COVID This adjusted $XX business a we represents private of revenue increase $XX about impacted equity of multiples. XXXX revenue million by not was given that in than clinical October launch by to Matrix XX% market EBITDA million, second especially an value substantial of XX% clinical or from million, negatively We with due faster XX% investment price, winding believe For reflected and QX future compared of our and the of for hidden the of share XXXX partially remain EBITDA the Matrix adjusted partner. was ModivCare revenue remains in and engaged XXXX. the aligned peer to vaccine quarter of is our expected $XX second in or Matrix’s $XXX business Matrix’s
provide as call. we mentioned full during our year year-and Lastly, last XXXX to we quarter, expect XXXX results guidance
that operator, for and adjusted prepared albeit between the the XX%. please concludes acquisition. following adjusted Finders open previous end revenue digits objectives care XX% With between of with to and margins Personal high-single Care in mid-single EBITDA EBITDA a margins growth before the questions. statements call on NEMT acquisition, the higher growth consistent and revenue operating long in remarks. term XX%, include However X% our This digits the